8:30 AM -  Funding Innovation in Cannabis
Charles Farkas, Loren DeFalco, Taz Turner, David Traylor

9:00 AM -  Cannabis Intellectual Property: A Moving Target
Benjamin Cameransi, Kevin McKernan, Jason Moscovici

• Is the history of IP in biotechnology a good comparison for cannabis IP?
• What are the current precedents for IP in cannabis?
• What will be the role of IP in the near- and long-term future of cannabis?

9:30 AM - Perspectives on Production: Cultivation, Chemistry and More
Trevor Shewfelt, Travis Higginbotham, David Traylor

• Some technologies that have been proven to be valuable to cannabis cultivation
• How will cultivation be applied in the future
• Is there different/optimal ways to produce different molecules?

10:00 AM - Molecules, the Future of Cannabis?
Dustin Sulak, Drew Hull, Rob McEvoy

10:30 AM -  Implications on Cannabis Rescheduling: Now and in the Future
Hunter Land, David Traylor, Eric Berlin, Ethan Russo

• Will reschedule happen and when?
• What are the positive and negative outcomes if Cannabis is rescheduled to Schedule 3?
• Who will benefit the most and who will not benefit the most of the rescheduling to Schedule 3?

11:00 AM - Cannabis and Cannabinoids: Where to From Here?
Ethan Russo, Hunter Land, Debra Kimless, David Traylor

• What are some good examples of previous inflection points in cannabis?
• Does cannabis have more frequent inflection points and can they be planned for?
• Can the management of technology inflection points be a competitive advantage?